Marksans Pharma Limited (MARKSANS) Financial Statements

6 Followers

Marksans Pharma Limited Financial Overview

Marksans Pharma Limited's market cap is currently ₹112.11B. The company's EPS TTM is ₹7.77; its P/E ratio is 27.61; and it has a dividend yield of 0.44%. Marksans Pharma Limited is scheduled to report earnings on May 26, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 29.51B	₹ 26.23B	₹ 21.77B	₹ 18.52B	₹ 14.80B
Gross Profit	₹ 11.57B	₹ 14.79B	₹ 11.03B	₹ 9.31B	₹ 7.32B
Operating Income	₹ 5.05B	₹ 11.29B	₹ 3.87B	₹ 3.00B	₹ 5.17B
EBITDA	₹ 6.03B	₹ 5.29B	₹ 5.09B	₹ 3.99B	₹ 3.01B
Net Income	₹ 4.18B	₹ 3.81B	₹ 3.14B	₹ 2.66B	₹ 1.85B
Balance Sheet
Cash & Short-Term Investments	₹ 9.90B	₹ 7.05B	₹ 7.00B	₹ 7.19B	₹ 3.47B
Total Assets	₹ 38.61B	₹ 32.40B	₹ 26.81B	₹ 21.90B	₹ 16.40B
Total Debt	₹ 3.43B	₹ 3.22B	₹ 2.44B	₹ 1.23B	₹ 1.11B
Net Debt	₹ -6.46B	₹ -3.82B	₹ -1.59B	₹ -2.59B	₹ -2.35B
Total Liabilities	₹ 8.08B	₹ 7.50B	₹ 5.95B	₹ 4.25B	₹ 4.17B
Stockholders' Equity	₹ 30.23B	₹ 24.67B	₹ 20.65B	₹ 17.45B	₹ 12.02B
Cash Flow
Free Cash Flow	₹ 3.51B	₹ 337.45M	₹ 215.69M	₹ 1.84B	₹ 529.27M
Operating Cash Flow	₹ 4.82B	₹ 2.07B	₹ 2.30B	₹ 2.37B	₹ 992.57M
Investing Cash Flow	₹ -2.75B	₹ -490.09M	₹ -1.41B	₹ -2.59B	₹ -416.86M
Financing Cash Flow	₹ -681.43M	₹ -651.46M	₹ -687.27M	₹ 1.98B	₹ 795.11M

Currency in INR

Marksans Pharma Limited Earnings and Revenue History

Income Statement >

Marksans Pharma Limited Debt to Assets

Balance Sheet >

Marksans Pharma Limited Cash Flow

Cash Flow >

Marksans Pharma Limited Forecast EPS vs Actual EPS

Earnings >